IgE against ethylene oxide-altered human serum albumin in patients with anaphylactic reactions to dialysis

Leslie C. Grammer; Bruce F. Paterson; David Roxe; John T. Daugirdas; Todd S. Ing; Peter T. Ivanovich; Colin B. Brown; Anthony J. Nicholls; Roy Patterson

doi:10.1016/0091-6749(85)90736-5

IgE against ethylene oxide-altered human serum albumin in patients with anaphylactic reactions to dialysis

Leslie C. Grammer^*, Bruce F. Paterson, David Roxe, John T. Daugirdas, Todd S. Ing, Peter T. Ivanovich, Colin B. Brown, Anthony J. Nicholls, Roy Patterson

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

Abstract

We have measured total antibody and IgE directed against ethylene oxide-altered human serum albumin (ETO-HSA) in the sera of 24 patients who have experienced anaphylaxis during hemodialysis and of 41 patients who have not had such episodes during hemodialysis. ETO is used to sterilize dialyzers and other medical equipment. The geometric mean level of IgE to ETO-HSA in patients with reactions (0.9 ng ETO-HSA bound to IgE per milliliter of serum) is significantly higher than in nonreacting patients (0.1 ng/ml, p < 0.0001). Sixteen of 24 patients with reactions had detectable levels of IgE to ETO-HSA, whereas only three of 41 nonreacting patients had detectable levels, (p < 0.0001 chi-square). The geometric mean level of total antibody to ETO-HSA is also significantly higher in patients with reactions (270 ng ETO-HSA bound per milliliter) than in nonreacting patients (31 ng/ml, p < 0.0001). Fourteen of 24 patients with reactions but only four of 39 nonreacting patients had total antibody binding of ETO-HSA (p < 0.0001 chi-square). These data extend our previous observations on a small group of 13 patients receiving hemodialysis (seven patients with reactions, and six nonreacting patients) and clearly demonstrate an association between the presence of IgE or total antibody to ETO-HSA and immediate anaphylactic reactions in this group of 65 patients receiving hemodialysis.

Original language	English (US)
Pages (from-to)	511-514
Number of pages	4
Journal	The Journal of allergy and clinical immunology
Volume	76
Issue number	3
DOIs	https://doi.org/10.1016/0091-6749(85)90736-5
State	Published - Sep 1985

Funding

From the Section of Allergy and Immunology and Section of Ne-phrology/Hypertension, Department of Medicine, Northwestern University Medical School, Chicago, Ill., *Department of Med-icine, Hines-Loyola Medical Center, Hines, Ill., and **Depart-ment of Nephrology and Transplantation, Royal Hallamshire Hospital, Sheffield University Medical School, Sheffield, En-gland. Supported by United States Public Health Service Grant AI-1 1403 and the Ernest S. Bazley Trust. Received for publication Sept. 24, 1984. Accepted for publication Jan. 14, 1985. Reprint requests: Leslie C. Grammer, M.D., Northwestern Uni-versity Medical School, 303 E. Chicago Ave., Chicago, IL 60611.

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/0091-6749(85)90736-5

Cite this

@article{5be49960d35944c29767e13cb07ec6f5,

title = "IgE against ethylene oxide-altered human serum albumin in patients with anaphylactic reactions to dialysis",

abstract = "We have measured total antibody and IgE directed against ethylene oxide-altered human serum albumin (ETO-HSA) in the sera of 24 patients who have experienced anaphylaxis during hemodialysis and of 41 patients who have not had such episodes during hemodialysis. ETO is used to sterilize dialyzers and other medical equipment. The geometric mean level of IgE to ETO-HSA in patients with reactions (0.9 ng ETO-HSA bound to IgE per milliliter of serum) is significantly higher than in nonreacting patients (0.1 ng/ml, p < 0.0001). Sixteen of 24 patients with reactions had detectable levels of IgE to ETO-HSA, whereas only three of 41 nonreacting patients had detectable levels, (p < 0.0001 chi-square). The geometric mean level of total antibody to ETO-HSA is also significantly higher in patients with reactions (270 ng ETO-HSA bound per milliliter) than in nonreacting patients (31 ng/ml, p < 0.0001). Fourteen of 24 patients with reactions but only four of 39 nonreacting patients had total antibody binding of ETO-HSA (p < 0.0001 chi-square). These data extend our previous observations on a small group of 13 patients receiving hemodialysis (seven patients with reactions, and six nonreacting patients) and clearly demonstrate an association between the presence of IgE or total antibody to ETO-HSA and immediate anaphylactic reactions in this group of 65 patients receiving hemodialysis.",

author = "Grammer, {Leslie C.} and Paterson, {Bruce F.} and David Roxe and Daugirdas, {John T.} and Ing, {Todd S.} and Ivanovich, {Peter T.} and Brown, {Colin B.} and Nicholls, {Anthony J.} and Roy Patterson",

note = "Funding Information: From the Section of Allergy and Immunology and Section of Ne-phrology/Hypertension, Department of Medicine, Northwestern University Medical School, Chicago, Ill., *Department of Med-icine, Hines-Loyola Medical Center, Hines, Ill., and **Depart-ment of Nephrology and Transplantation, Royal Hallamshire Hospital, Sheffield University Medical School, Sheffield, En-gland. Supported by United States Public Health Service Grant AI-1 1403 and the Ernest S. Bazley Trust. Received for publication Sept. 24, 1984. Accepted for publication Jan. 14, 1985. Reprint requests: Leslie C. Grammer, M.D., Northwestern Uni-versity Medical School, 303 E. Chicago Ave., Chicago, IL 60611.",

year = "1985",

month = sep,

doi = "10.1016/0091-6749(85)90736-5",

language = "English (US)",

volume = "76",

pages = "511--514",

journal = "The Journal of allergy and clinical immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - IgE against ethylene oxide-altered human serum albumin in patients with anaphylactic reactions to dialysis

AU - Grammer, Leslie C.

AU - Paterson, Bruce F.

AU - Roxe, David

AU - Daugirdas, John T.

AU - Ing, Todd S.

AU - Ivanovich, Peter T.

AU - Brown, Colin B.

AU - Nicholls, Anthony J.

AU - Patterson, Roy

N1 - Funding Information: From the Section of Allergy and Immunology and Section of Ne-phrology/Hypertension, Department of Medicine, Northwestern University Medical School, Chicago, Ill., *Department of Med-icine, Hines-Loyola Medical Center, Hines, Ill., and **Depart-ment of Nephrology and Transplantation, Royal Hallamshire Hospital, Sheffield University Medical School, Sheffield, En-gland. Supported by United States Public Health Service Grant AI-1 1403 and the Ernest S. Bazley Trust. Received for publication Sept. 24, 1984. Accepted for publication Jan. 14, 1985. Reprint requests: Leslie C. Grammer, M.D., Northwestern Uni-versity Medical School, 303 E. Chicago Ave., Chicago, IL 60611.

PY - 1985/9

Y1 - 1985/9

N2 - We have measured total antibody and IgE directed against ethylene oxide-altered human serum albumin (ETO-HSA) in the sera of 24 patients who have experienced anaphylaxis during hemodialysis and of 41 patients who have not had such episodes during hemodialysis. ETO is used to sterilize dialyzers and other medical equipment. The geometric mean level of IgE to ETO-HSA in patients with reactions (0.9 ng ETO-HSA bound to IgE per milliliter of serum) is significantly higher than in nonreacting patients (0.1 ng/ml, p < 0.0001). Sixteen of 24 patients with reactions had detectable levels of IgE to ETO-HSA, whereas only three of 41 nonreacting patients had detectable levels, (p < 0.0001 chi-square). The geometric mean level of total antibody to ETO-HSA is also significantly higher in patients with reactions (270 ng ETO-HSA bound per milliliter) than in nonreacting patients (31 ng/ml, p < 0.0001). Fourteen of 24 patients with reactions but only four of 39 nonreacting patients had total antibody binding of ETO-HSA (p < 0.0001 chi-square). These data extend our previous observations on a small group of 13 patients receiving hemodialysis (seven patients with reactions, and six nonreacting patients) and clearly demonstrate an association between the presence of IgE or total antibody to ETO-HSA and immediate anaphylactic reactions in this group of 65 patients receiving hemodialysis.

AB - We have measured total antibody and IgE directed against ethylene oxide-altered human serum albumin (ETO-HSA) in the sera of 24 patients who have experienced anaphylaxis during hemodialysis and of 41 patients who have not had such episodes during hemodialysis. ETO is used to sterilize dialyzers and other medical equipment. The geometric mean level of IgE to ETO-HSA in patients with reactions (0.9 ng ETO-HSA bound to IgE per milliliter of serum) is significantly higher than in nonreacting patients (0.1 ng/ml, p < 0.0001). Sixteen of 24 patients with reactions had detectable levels of IgE to ETO-HSA, whereas only three of 41 nonreacting patients had detectable levels, (p < 0.0001 chi-square). The geometric mean level of total antibody to ETO-HSA is also significantly higher in patients with reactions (270 ng ETO-HSA bound per milliliter) than in nonreacting patients (31 ng/ml, p < 0.0001). Fourteen of 24 patients with reactions but only four of 39 nonreacting patients had total antibody binding of ETO-HSA (p < 0.0001 chi-square). These data extend our previous observations on a small group of 13 patients receiving hemodialysis (seven patients with reactions, and six nonreacting patients) and clearly demonstrate an association between the presence of IgE or total antibody to ETO-HSA and immediate anaphylactic reactions in this group of 65 patients receiving hemodialysis.

UR - http://www.scopus.com/inward/record.url?scp=0021967824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021967824&partnerID=8YFLogxK

U2 - 10.1016/0091-6749(85)90736-5

DO - 10.1016/0091-6749(85)90736-5

M3 - Article

C2 - 4031322

AN - SCOPUS:0021967824

SN - 0091-6749

VL - 76

SP - 511

EP - 514

JO - The Journal of allergy and clinical immunology

JF - The Journal of allergy and clinical immunology

IS - 3

ER -

IgE against ethylene oxide-altered human serum albumin in patients with anaphylactic reactions to dialysis

Abstract

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this